Acute treatment response in outpatients with panic disorder: High versus low depressive symptoms

D. W. Black, R. Wesner, W. Bowers, Patrick Monahan, J. Gabel

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The authors studied 75 outpatients with DSM-III-R panic disorder who had participated in a clinical trial and had been randomly assigned to receive fluvoxamine, cognitive therapy, or placebo for an 8-week period. They compared a group with high levels of depressive symptoms and a group with low levels of depressive symptoms. At baseline, patients with high levels of depressive symptoms were more likely to have severe phobic avoidance and to have higher scores on measures of anxiety, hypochondriasis, and disability. An important finding was that depressive symptoms improved at a rate which paralleled improvement in panic and anxiety. Likewise, the presence of depressive symptoms did not interfere with treatment response in panic disorder. Clinical implications of the findings are discussed.

Original languageEnglish (US)
Pages (from-to)181-188
Number of pages8
JournalAnnals of Clinical Psychiatry
Volume7
Issue number4
StatePublished - 1995
Externally publishedYes

Fingerprint

Panic Disorder
Outpatients
Depression
Anxiety
Hypochondriasis
Fluvoxamine
Therapeutics
Panic
Cognitive Therapy
Diagnostic and Statistical Manual of Mental Disorders
Placebos
Clinical Trials

Keywords

  • Cognitive therapy
  • Depression
  • Fluvoxamine
  • Panic disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Acute treatment response in outpatients with panic disorder : High versus low depressive symptoms. / Black, D. W.; Wesner, R.; Bowers, W.; Monahan, Patrick; Gabel, J.

In: Annals of Clinical Psychiatry, Vol. 7, No. 4, 1995, p. 181-188.

Research output: Contribution to journalArticle

@article{ec209cc2c320468e98aacd6f30722987,
title = "Acute treatment response in outpatients with panic disorder: High versus low depressive symptoms",
abstract = "The authors studied 75 outpatients with DSM-III-R panic disorder who had participated in a clinical trial and had been randomly assigned to receive fluvoxamine, cognitive therapy, or placebo for an 8-week period. They compared a group with high levels of depressive symptoms and a group with low levels of depressive symptoms. At baseline, patients with high levels of depressive symptoms were more likely to have severe phobic avoidance and to have higher scores on measures of anxiety, hypochondriasis, and disability. An important finding was that depressive symptoms improved at a rate which paralleled improvement in panic and anxiety. Likewise, the presence of depressive symptoms did not interfere with treatment response in panic disorder. Clinical implications of the findings are discussed.",
keywords = "Cognitive therapy, Depression, Fluvoxamine, Panic disorder",
author = "Black, {D. W.} and R. Wesner and W. Bowers and Patrick Monahan and J. Gabel",
year = "1995",
language = "English (US)",
volume = "7",
pages = "181--188",
journal = "Annals of Clinical Psychiatry",
issn = "1040-1237",
publisher = "Dowden Health Media,Inc",
number = "4",

}

TY - JOUR

T1 - Acute treatment response in outpatients with panic disorder

T2 - High versus low depressive symptoms

AU - Black, D. W.

AU - Wesner, R.

AU - Bowers, W.

AU - Monahan, Patrick

AU - Gabel, J.

PY - 1995

Y1 - 1995

N2 - The authors studied 75 outpatients with DSM-III-R panic disorder who had participated in a clinical trial and had been randomly assigned to receive fluvoxamine, cognitive therapy, or placebo for an 8-week period. They compared a group with high levels of depressive symptoms and a group with low levels of depressive symptoms. At baseline, patients with high levels of depressive symptoms were more likely to have severe phobic avoidance and to have higher scores on measures of anxiety, hypochondriasis, and disability. An important finding was that depressive symptoms improved at a rate which paralleled improvement in panic and anxiety. Likewise, the presence of depressive symptoms did not interfere with treatment response in panic disorder. Clinical implications of the findings are discussed.

AB - The authors studied 75 outpatients with DSM-III-R panic disorder who had participated in a clinical trial and had been randomly assigned to receive fluvoxamine, cognitive therapy, or placebo for an 8-week period. They compared a group with high levels of depressive symptoms and a group with low levels of depressive symptoms. At baseline, patients with high levels of depressive symptoms were more likely to have severe phobic avoidance and to have higher scores on measures of anxiety, hypochondriasis, and disability. An important finding was that depressive symptoms improved at a rate which paralleled improvement in panic and anxiety. Likewise, the presence of depressive symptoms did not interfere with treatment response in panic disorder. Clinical implications of the findings are discussed.

KW - Cognitive therapy

KW - Depression

KW - Fluvoxamine

KW - Panic disorder

UR - http://www.scopus.com/inward/record.url?scp=0029549089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029549089&partnerID=8YFLogxK

M3 - Article

C2 - 8721892

AN - SCOPUS:0029549089

VL - 7

SP - 181

EP - 188

JO - Annals of Clinical Psychiatry

JF - Annals of Clinical Psychiatry

SN - 1040-1237

IS - 4

ER -